Finzati - Logo
CRIS logo

Curis, Inc.

CRIS • Biotechnology
$0.00
— 0.00 (0.00%)
EarningsLatest report: Mar 31, 2026
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$2.71M
Growth
-20.7%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.3Weak liquidity · 0.49Negative growth trendWeak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 12, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$2.71M
52W Range0.18 - 2.48
Beta3.08
Gross Margin99.52%
Oper. Margin-3.48%
Profit Margin-80.29%
Debt/Eq0.30
Current Ratio0.49
Quick Ratio0.49
Revenue 5Y-20.72%

Investment DNA

How strong this company looks for long-term investors

24
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
38/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Manageable debt level · 0.3Weak liquidity · 0.49Negative growth trendWeak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 8/1/2000
Industry: Biotechnology
P/B i: 23.79
Debt / Equity i: 0.30
Operating Margin: -348.43%
Net Margin: -80.29%
ROE i: -
ROIC: -

Financial Health

Score8 / 20
Debt / Equity: 0.30
Current Ratio: 0.49
Quick Ratio: 0.49
Status: Moderate

Warnings

  • Weak Liquidity
  • Weak quick ratio

Insider Transactions

Recent executive and insider activity

KAITIN KENNETH I
Transaction: 03/31/2026
BUY
Change
+10,000
Price
$0.55
Filing
04/01/2026
Type
BUY
Rubin Marc
Transaction: 03/20/2026
SELL
Change
-20
Price
Not reported
Filing
03/23/2026
Type
SELL
Rubin Marc
Transaction: 03/20/2026
BUY
Change
+26,667
Price
Not reported
Filing
03/23/2026
Type
BUY